Avinesh Singh Bhar Jaswindar Singh, MD
Pulmonary Disease · Macon, GANPI 1760634505
Payments from drug & device makers
Across 56 payments — averaging $45.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$618
- SK Life Science, Inc.$485
- GSK$214
- Boehringer Ingelheim$200
- Regeneron Healthcare Solutions, Inc.$146
- Mylan Specialty L.p.$134
- plus $736 from 13 others
What the payments were for
- Food & beverage$2,51799%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 11 | $618 |
| SK Life Science, Inc. | 4 | $485 |
| GSK | 7 | $214 |
| Boehringer Ingelheim | 6 | $200 |
| Regeneron Healthcare Solutions, Inc. | 7 | $146 |
| Mylan Specialty L.p. | 2 | $134 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Pfizer | 1 | $125 |
| Silk Road Medical, Inc. | 1 | $121 |
| Jazz Pharmaceuticals Inc. | 2 | $109 |
| Grifols USA, LLC | 5 | $101 |
| Sunovion Pharmaceuticals Inc. | 2 | $34 |
| Fisher & Paykel Healthcare Inc | 1 | $21 |
| United Therapeutics Corporation | 1 | $21 |
| Pulmonx Corporation | 1 | $20 |
| Advanced Respiratory, Inc | 1 | $18 |
| Covidien LP | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XCOPRI$485
- ELIQUIS$250
- BREZTRI$131
- ANORO$125
- FASENRA$125
- LOKELMA$125
- Yupelri$121
- ENROUTE Transcarotid Neuroprotection System$121
- ENROUTE Transcarotid Stent System$121
- ENHANCE Transcarotid Peripheral Access Kit$121
- ENROUTE 0.014 Guidewire$121
- SOLIRIS$112
- XYREM$108
How this compares
$2,533 in reported general payments places this provider in the 30th percentile of 365 pulmonary disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 13 | $140 |
| Montelukast Sodium | 25 | $106 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Macon
- Gerald TarirahMacon$38K
- Maria MascoloRincon$2.7M
- Chad MillerAustell$2M
- Amy CaseAustell$1.5M
- Srihari VeeraraghavanAtlanta$1.3M
- Jose MedinaValdosta$1.3M
- Micah FisherAtlanta$1.2M
- Frances LeeAtlanta$1.2M
- Vijay PatelNewnan$1.1M
- Lawrence McDermottSavannah$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.